Physician profile
Michael Marchese
NPI 1427287564
$1,984.21
in general payments reported to CMS, 2019-2025
10 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2021: $443 · 2022: $701 · 2023: $139 · 2024: $134 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.39 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $610.00 | 2021-2022 | |
| Davol INC. | $387.97 | 2019-2022 | |
| Amgen INC. | $275.01 | 2019-2024 | Repatha |
| Radius Health, INC. | $174.54 | 2019-2024 | Tymlos |
| Becton, Dickinson and Company | $162.71 | 2022 | |
| Novo Nordisk INC | $125.00 | 2023 | |
| Insulet Corporation | $110.79 | 2025 | Omnipod |
| Zimmer Biomet Holdings, INC. | $90.78 | 2025 | Traumaone |
| Depuy Synthes Sales INC. | $26.97 | 2022 | |
| Lilly USA, LLC | $20.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marchese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.